Roderbruch market. We will do this together in the orientation weeks!! E-mail: In case you want an-email address at the MHH, please ask your respective department / institute secretary.
Osten Dr. rer. nat. Contact: Phone: +49 511 532-2759 (office) -3654 (lab) Fax: +49 511 532-161215 Address: Carl-Neuberg-Straße 1, 30625 Hannover, Germany Building 03, level 03, room 1320 ResearchGate: R
Ante Radocaj Dr. rer. nat. Contact ► Ante Radocaj Tel: +49 511 532 -2630 Fax: +49 511 532-161215 address: 30625 Hannover, Carl-Neuberg-Str.1, Germany Building J03, level 03, room 1283 Career seit 2007 Postdoc
available for booking on the MHH exchange server. For this purpose, the user must have an MHH e-mail address, which can be requested from the Center for Information Management (ZIMt). - Sample preparation:
REFEREE Please name your current supervisor as your first referee. Please ensure that the email address is absolutely correct. The system will send a link and code (login) to your referee, so that he or
between patients and doctors is particularly affected by this. With our future discourse, we are addressing a series of new and previously unresolved questions: Should doctors view diagnostic systems based
the financial and legal protection of the donor, we would like to recommend the following internet address: Transplantation verstehen Contact: Coordinators: Mrs. Susann Schumann, Mrs. Christel Koczur ☎ 0511
MZP, Sarah Konze Contact ► Sarah Konze Tel: +49 511 532 -2754 (office) Fax: +49 511 532-161215 address: Germany 30625 Hannover, Carl-Neuberg-Str.1 building J03, floor 03, room 1330 Curriculum Vitae Since
/VMTA) Contact ► Birgit Piep Tel: +49 511 532 -3604 (office), -3654 (lab) Fax: +49 511 532-161215 address: Germany 30625 Hannover, Carl-Neuberg-Str.1 ► Birgit Piep ► Research Gate ► Research Network - Frontiers
finding alternative methods to animal experiments. Therefore, the following research areas are addressed in the RG Martin: 1. Reprogramming of somatic cells into clinically applicable induced pluripotent [...] to avoid the activation of proto-oncogenes and the formation of teratomas (germ cell tumors). To address an additional safety concern of the therapeutic use of iPS cells and their derivatives, we are e [...] into induced pluripotent stem cells for safer therapies. (Created with BioRender. com) In order to address further safety aspects of iPSC-based therapies, we investigate the application of so-called suicide